Literature DB >> 16479146

Practical use of MESNA in atelectatic ears and adhesive otitis media.

Metin Yilmaz1, Nebil Goksu, Ismet Bayramoglu, Yildirim A Bayazit.   

Abstract

OBJECTIVE: MESNA is a synthetic sulfur compound that produces mucolysis by disrupting disulfide bonds. This study aimed to address indications and technique of MESNA application in otologic surgery, especially in retraction pockets and adhesive otitis media.
METHODS: MESNA application was performed in 42 ears of 39 patients. The diagnoses were retraction pockets fixed to incudostapedial joint, stapes or promontorium, and adhesive otitis media in 24 and 17 ears, respectively. Calculations were performed according to 24 ears of 23 patients with follow-up data.
RESULTS: One or more of the following surgical interventions were performed: MESNA application alone and ventilation tube insertion, reinforcement or mastoidectomy in addition to MESNA application. Sensorineural hearing loss was not encountered after MESNA application. The operation was successful in 79.2%. Overall revision surgery was needed in 20.8% of the ears. In 71.4% of the ears treated with MESNA alone, revision surgery was needed.
CONCLUSION: In the light of our experience, we advocate the use of MESNA in atelectatic ears, because it makes the operation easy and safe by allowing elevation of the tympanic membrane by its mechanical and chemical actions. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479146     DOI: 10.1159/000091472

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  9 in total

Review 1.  Tympanic membrane retraction pocket staging: is it worthwhile?

Authors:  Musaed Alzahrani; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-27       Impact factor: 2.503

2.  Electrophysiological and Histopathological Evaluation of Effects of Sodium-2 Mercaptoethanesulfonate Used for Middle Ear Surgery on Facial Nerve Functions.

Authors:  Oğuz Kadir Eğilmez; Numan Kökten; Mustafa Baran; M Tayyar Kalcıoğlu; Işın Doğan Ekici; Muhammet Tekin
Journal:  J Int Adv Otol       Date:  2018-08       Impact factor: 1.017

3.  After myringotomy, can topical Mesna application be an alternative method to ventilation tube application?

Authors:  Rifat Karli; Fatih Ilkaya; Arzu Karli; Emre Gunbey; Harun Kucuk; Hasan Guzel; Emre Ayhan
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-08       Impact factor: 2.503

4.  The effects of sodium-2-mercaptoethanesulfonate application on the neural and neurovascular tissues: An experimental animal study.

Authors:  Ayca Ant; Recep Karamert; Gamze Kulduk; Özgür Ekinci; Hakan Tutar; Nebil Göksu
Journal:  Surg Neurol Int       Date:  2015-09-18

Review 5.  A Review: Expression of Aquaporins in Otitis Media.

Authors:  Su Young Jung; Sung Su Kim; Young Il Kim; Sang Hoon Kim; Seung Geun Yeo
Journal:  Int J Mol Sci       Date:  2017-10-17       Impact factor: 5.923

Review 6.  Expression, Distribution, and Role of C-Type Lectin Receptors in the Human and Animal Middle Ear and Eustachian Tube: A Review.

Authors:  Su Young Jung; Sung Su Kim; Young Il Kim; Hee Yong Chung; Sang Hoon Kim; Seung Geun Yeo
Journal:  Molecules       Date:  2018-03-22       Impact factor: 4.411

7.  A clinical and histopathological comparison of saline, adrenaline and 2-mercaptoethanesulfonate (MESNA) in mucoperichondrial elevation: which is superior?

Authors:  Zehra Çınar; Özgür Yiğit; Fulya Savran Turanoğlu; Sevim Baykal Koca
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-02       Impact factor: 2.124

8.  Inhibitory effect of mesna and 5-fluorouracil on propylene glycol-induced cholesteatoma in rats.

Authors:  Numan Kokten; Ozan Tuysuz; Tulay Zenginkinet; Fatih Mehmet Hanege; Mahmut Tayyar Kalcioglu
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-10       Impact factor: 2.124

9.  Mesna ameliorates acute lung injury induced by intestinal ischemia-reperfusion in rats.

Authors:  Samia Adel Abd El-Baset; Manal R Abd El-Haleem; Rehab S Abdul-Maksoud; Asmaa A A Kattaia
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.